Olink

Olink®
Part of Thermo Fisher Scientific

Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction

European Heart Journal, 2024

Reddy Y., Melenovsky V., Asokan A., Haluzik M., Carter R., Nair S., Jensen M., Borlaug B.

Disease areaApplication areaSample typeProducts
Metabolic Diseases
CVD
Pathophysiology
Plasma
O

Olink Explore 3072/384

Abstract

Rapid communication article, no abstract.

Read publication ↗